Task: Answer Verification
Input (English): Question: Does the potent somatostatin analogue vapreotide decrease pancreas-specific complications after elective pancreatectomy : a prospective , multicenter , double-blinded , randomized , placebo-controlled trial?
Answer: The potent somatostatin analogue vapreotide does not appear to decrease postoperative complications after major pancreatectomy in patients without chronic pancreatitis.
Output (English): no